Fonar (FONR) Float Percentage Of Total Shares Outstanding : 95.82% (As of Apr. 27, 2024)

View and export this data going back to 1981. Start your Free Trial

What is Fonar Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Fonar's float shares is 6.19 Mil. Fonar's total shares outstanding is 6.46 Mil. Fonar's float percentage of total shares outstanding is 95.82%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Fonar's Insider Ownership is 3.33%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Fonar's Institutional Ownership is 23.86%.

Fonar Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Fonar's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding	=	Float Shares	/	Total Shares Outstanding
	=	6.19	/	6.46
	=	95.82%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fonar (FONR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Fonar Corp (NAS:FONR) » Definitions » Float Percentage Of Total Shares Outstanding

Comparable Companies

Traded in Other Exchanges

FOAA:Germany

Address

110 Marcus Drive, Melville, NY, USA, 11747

Website

https://www.fonar.com

Fonar Corp is a United States-based company which is engaged in the business of designing, manufacturing, selling and servicing magnetic resonance imaging (MRI) scanners, which utilize MRI technology for the detection and diagnosis of human disease, abnormalities, other medical conditions, and injuries. The company operates through two segments namely Manufacturing and servicing of medical equipment; and the Management of diagnostic imaging centers, which generates a vast majority of the revenue. The company's areas of operations are principally in the United States. It also exports to the United Arab Emirates, England, and Germany.

Executives

Timothy Raymond Damadian	director, officer: CEO, President & Treasurer	110 MARCUS DR., MELVILLE NY 11747
Luciano B Bonanni	officer: Exec VP, COO & PFO	110 MARCUS DR., MELVILLE NY 11747
Raymond V Damadian	director, officer: president	31 FAIRBANKS BLVD, WOODBURY NY 11797
Robert J Janoff	director	32 OSAGE DRIVE, HUNTINGTON STATION NY 11746
Data Charles O	director	347 LINCOLN AVENUE, BEAVER PA 15009
Claudette Chan	director	145 WEST 86TH STREET, APT. 15B, NEW YORK NY 10024
David B Terry	officer: Secretary	BOX 1439, EAST QUOGUE NY 11942
Robert Djerejian	director	303 EAST 57TH STREET, APT 16LA, NEW YORK NY 10022